Laura Alder: New Treatments With Meaningful CNS Efficacy Changing the Conversation For Patients
Laura Alder/X

Laura Alder: New Treatments With Meaningful CNS Efficacy Changing the Conversation For Patients

Laura Alder, Medical Oncology Deputy Director at Duke Center for Brain and Spine Metastasis, shared a post on LinkedIn:

“What a privilege to join Misty Shields and Ann Steagall of LUNGevity Foundation to discuss “SCLC and Brain Metastases” on the SCLC Smashers Fireside chat!

Watch the entire episode here

There is real Hope right now! We’re seeing new treatments with meaningful CNS efficacy that are changing the conversation for our patients.

But hope must be matched with Action. We need to ensure our clinical trials are inclusive. Every patient deserves access to the breakthroughs that could change their life.

Thank you to the SCLC Smashers and LUNGevity Foundation community for the incredible work you do.”

Laura Alder

Other articles featuring Laura Alder on OncoDaily.